Skip to main content
Caplight Logo









Oncologica

Oncologica

Private
Saffron WaldenHealthcare & Life Scienceshttps://oncologica.com

Last Round

Early Funding

Apr 27, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oncologica operates in Healthcare & Life Sciences and is based in Saffron Walden. Its latest recorded funding round was an Early Funding round in April 2026.

Oncologica is a precision oncology company that provides genomic profiling, diagnostic testing, and contract research services to support personalized cancer medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Oncologica Comparables

Compare Oncologica with similar companies based on industry and business-model similarity.

No comparables are published for Oncologica. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Oncologica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 27, 2026
Early FundingSep 14, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Evgeny Dmitriev

Consultant CFO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 74% MoM, reaching 3.6K.

  • Jun 19, 2026

    Monthly visitors grew 120% MoM, reaching 2.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Oncologica Filings

Explore SEC and related filing metadata, where available.

Oncologica filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Oncologica's valuation, stock price, and market status.

Is Oncologica a public or private company?

Oncologica is a private company.

What is the current stock price of Oncologica?

Oncologica is a private company, so its shares have no public market price. Caplight tracks Oncologica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Oncologica worth (valuation)?

Valuation information for Oncologica is not publicly available.

Can I buy Oncologica stock?

Oncologica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Oncologica's last funding round?

Oncologica's most recent funding round was Early Funding on April 27, 2026.

Who are the main investors in Oncologica?

Investor information for Oncologica is not publicly disclosed.

Will Oncologica IPO soon?

No public IPO plans have been announced for Oncologica.

How can I track Oncologica secondary market activity?

Caplight tracks bids, offers, and trades in Oncologica's shares on secondary markets.

Firmographic Details

HeadquartersSaffron Walden
Employee Range29
Year Founded2014
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?